异维A酸二茂铁基衍生物的合成及其细胞毒活性的研究

为降低异维A酸的毒副作用并提高其癌细胞毒活性以及增加其在生物体内的吸收, 通过Mitsunobu反应, 以高于80%的收率合成了8种新异维A酸二茂铁基衍生物, 并进行了结构表征与确认. 采用3-(4,5-二甲基噻唑-2)-2,5-二苯基四唑溴盐(MTT)法测试了它们对肺癌细胞(A549)等的癌细胞毒活性. 结果显示, 引入二茂铁基团后的异维A酸二茂铁基衍生物具有很好的癌细胞毒活性.     

13-cis-异维A酸衍生物的合成、表征及抗癌活性研究

以六甲基磷酰胺为溶剂,在室温条件下将异维A酸合成为尚未见文献报道的异维A酸衍生物(4a～4g),其结构经^1H NMR,^13C NMR和MS表征。着重考察了4g的生物活性,结果表明该4g对肝癌细胞,舌癌细胞等具有抗癌活性。     

新型芳基修饰的藤黄酸衍生物的合成及其抗肿瘤活性

以取代酚或羟基吡啶为原料,在无水碳酸钾存在下,与溴代醇发生威廉姆森醚合反应制得中间体--芳（杂环）氧基醇(2a~2k); 2a~2k分别与藤黄酸通过光延反应合成了藤黄酸衍生物（3a~3k）。以DDC/HOSu为偶联剂,芳酸与3-氨基-1-丙醇经偶联反应制得中间体--芳酰氨基醇（5a~5h）; 5a~5h分别与藤黄酸通过光延反应合成了藤黄酸衍生物（6a~6h）。 2, 3, 5和6为新化合物,其结构经¹H NMR, ESI-MS和HR-MS表征。采用MTT法测定了3和6对肺腺癌细胞(A549)、肝癌细胞(HepG-2)和乳腺癌细胞(SK-BR-3)的体外抗肿瘤活性。结果表明：部分化合物对肿瘤细胞的抑制活性明显高于藤黄酸。     

异维A酸4-氨基安替比林席夫碱酯的合成

以二环己基碳酰亚胺为脱水剂,4-二甲氨基吡啶为催化剂,异维A酸与甲酰基酚发生酯化反应生成了异维A酸酯(1a~1d);1再与4-氨基安替比林反应,合成了4个异维A酸4-氨基安替比林席夫碱酯(2a~2d)。2的结构由1HNMR,IR和MS确证。     

新型4'-(N-取代-1-哌嗪基)查尔酮衍生物的合成及其抗肿瘤活性

为了寻找活性较高的抗肿瘤新型分子,采用活性亚结构拼接的方法,将查尔酮和哌嗪连接起来,并通过衍生化,设计合成了10个未见文献报道的新型4'-(N-取代-1-哌嗪基)查尔酮衍生物3a~3j,其结构经~1H NMR、~(13)C NMR和HRMS确证.采用溴化噻唑蓝四氮唑(MTT)法测试了目标化合物体外抗肿瘤活性(Hela,A549和SGC7901),结果表明化合物3f、3i和3j均表现出良好的细胞毒活性,可做进一步研究.     

新型1,2,3-三唑类化合物的合成及抗菌构效关系

根据活性基团拼接原理, 以4-取代-苯胺为原料, 经重氮化、 关环和缩合反应合成了17个化合物1-(4-取代苯基)-5-取代苯基亚氨基-4-取代-1,2,3-三唑(7a~7c和13a~13d)和1-(4-取代苯基)-5-取代苄基氨基-4-取代-1,2,3-三唑(5a~5c, 10a~10c和14a~14d), 其中化合物5a~5c, 7b, 7c, 10a, 10c, 13b~13d和14b~14c为新化合物, 对所制备化合物的结构进行了表征. 生物活性测试结果表明, 所有化合物均表现出一定的抑菌活性, 对大肠杆菌的抑菌活性均优于氟康唑; 化合物7a和10c对金黄色葡萄球菌的抑制活性明显优于氟康唑; 而化合物13a和13d则对白色念球菌表现出良好的抑制活性, 与三氯生相当.     

18β-甘草次酸A环开环衍生物的合成及抗肿瘤活性

采用化学方法在18β-甘草次酸A环上进行结构修饰,合成了一系列新颖的A环具有不同官能团的开环衍生物.初步研究了它们对人体肝癌细胞HepG-2的体外细胞毒活性,结果表明,羟基的数目和位置对抑制HepG-2细胞增殖起着重要的作用.     

异维A酸新木脂素酯的合成与表征

以香草醛(或对羟基苯甲醛)和丙二酸为原料,经Knoevenagel反应、酯化、氧化银为氧化剂的自由基仿生氧化偶联反应合成了新木脂素3a,3b。3a,3b分别与异维A酸酯化,合成了两种新型的异维A酸新木脂素酯4a和4b。用1H NMR,IR和MS对它们的结构进行了表征。研究了异维A酸酯的反应机理。     

含N-烷基哌嗪取代呋喃查尔酮类化合物的合成及其 生物活性评价

为了寻找结构新颖的生物活性分子,采用活性亚结构拼接原理设计合成了12个哌嗪取代呋喃查尔酮衍生物(3a~3l),其结构经~1H NMR、~(13)C NMR和HRMS确证。分别采用MTT法和小鼠巨噬细胞Raw264.7炎症模型对目标化合物的体外细胞毒活性和抗炎活性进行测试,结果表明,哌嗪环上的取代基对化合物的生物活性有明显的影响。特别是化合物3j和3k对肿瘤细胞株Hela和A549均表现出良好的体外抑制活性,而且化合物3d能有效抑制NO的生成,值得进一步研究。     

新型4-取代苯胺喹唑啉衍生物的合成与抗肿瘤活性研究

以6-碘喹唑啉-4-酮为原料,经氯代、胺化、Suzuki偶联、Wittig-horner等反应合成了7个新型的4 取代苯胺喹唑啉衍生物(5a~5g),其结构经¹H NMR和HR-MS(ESI)表征。采用MTT法研究了5a~5g对人乳腺癌细胞(MCF-7)、人肺癌细胞(A549)和人皮肤鳞癌细胞（A431）的抑制活性。结果表明：5a~5g对肿瘤细胞均具有明显的抑制活性;其中5e的抑制活性(IC₅₀=0.13~5.26 μmol·L^-1)优于拉帕替尼(IC₅₀=0.21~15.56 μmol·L^-1)。     

Synthesis and in vitro cytotoxic evaluation of 2-hydrazinylpyrido[2,3-b]pyrazin-3(4H)-one derivatives

A series of novel 2-hydrazinylpyrido[2,3-b]pyrazin-3（4H）-one derivatives were synthesized and evaluated for their cytotoxic activities against A549,MDA-MB-231 and HT-29 cell lines in vitro.Pharmacological data indicated that compounds 5b,5c,10a and 10g possessed marked cytotoxicity,especially 10a(with IC₅₀ values of 0.81,2.56 and 1.63μmol/L against A549,MDA-MB- 23 1 and HT29 cell lines,respectively),which had emerged as a lead compound.     

大黄酸-缬氨酸加合物的合成及初步抗肿瘤活性

以大黄酸为原料,经酯化、烷基化、水解及缩合等反应步骤合成了12个大黄酸-缬氨酸加合物.目标化合物经1H NMR,~(13)C NMR和HRMS进行了结构确证.以顺铂和阿霉素为阳性对照药,采用四甲基偶氮唑盐(MTT)法考察了目标化合物的体外抗肿瘤(Hela,MCF-7,HepG2,KB和HEK293T等5株细胞)活性.结果表明,化合物5l显示出较好的抗肿瘤活性,其IC50值在1.6~9.4μmol/L之间.作用机制研究结果表明,化合物5l能够与DNA发生较强的结合作用.     

Studies on glycosylation of the mitomycins. Syntheses of 7-N-(4-O-glycosylphenyl)-9a-methoxymitosanes

Two new derivatives of glycosyl mitomycin C, 7-N-[4-O-(beta-D-glucopyranosyl and alpha-sialosyl)phenyl]-9a- methoxymitosanes, were synthesized, and their structures were elucidated by analysis of the nuclear magnetic resonance spectra. Field desorption mass spectrometry was successfully used for the confirmation of these structures. The cytotoxic, antibacterial, and antitumor activities of 7-N-(4-glycosylphenyl)-9a- methoxymitosanes were also examined.     

Design,synthesis and biological evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines

A series of novel arylpiperazine derivatives was synthesized. The in vitro cytotoxic activities of all synthesized compounds against three human prostate cancer cell lines(PC-3, LNCa P, and DU145) were evaluated by a CCK-8 assay. Compounds 8, 10, 13, 17 and 20 exhibited strong cytotoxic activities against the tested cancer cell lines(IC_(50)3 μmol/L). In addition, these compounds exhibited weak cytotoxic effects on human epithelial prostate normal cells WPMY-1. The structure–activity relationship(SAR) of these arylpiperazine derivatives was also discussed based on the obtained experimental data.     

Design,Synthesis, Biological Evaluation and Silico Prediction of Novel Sinomenine Derivatives

Sinomenine is a morphinan alkaloid with a variety of biological activities. Its derivatives have shown significant cytotoxic activity against different cancer cell lines in many studies. In this study, two series of sinomenine derivatives were designed and synthesized by modifying the active positions C₁ and C₄ on the A ring of sinomenine. Twenty-three compounds were synthesized and characterized by spectroscopy (IR, ¹H-NMR, ¹³C-NMR, and HRMS). They were further evaluated for their cytotoxic activity against five cancer cell lines, MCF-7, Hela, HepG2, SW480 and A549, and a normal cell line, Hek293, using MTT and CCK8 methods. The chlorine-containing compounds exhibited significant cytotoxic activity compared to the nucleus structure of sinomenine. Furthermore, we searched for cancer-related core targets and verified their interaction with derivatives through molecular docking. The chlorine-containing compounds 5g, 5i, 5j, 6a, 6d, 6e, and 6g exhibited the best against four core targets AKT1, EGFR, HARS and KARS. The molecular docking results were consistent with the cytotoxic results. Overall, results indicate that chlorine-containing derivatives might be a promising lead for the development of new anticancer agents.     

Hyperisampsins N and O,two new benzoylated phloroglucinol derivatives from Hypericum sampsonii

Twenty-one benzoylated phloroglucinol derivatives bearing homoadamantyl frameworks were isolated from the aerial parts of Hypericum sampsonii, including two new ones named hyperisampsins N and O (1 and 2). The structures of 1 and 2 were elucidated by extensive NMR and mass spectrometric analyses. Their absolute configurations were further determined by using TDDFT ECD calculations. Compounds 2, 7, and 8 were evaluated for their cytotoxic activities against five human cancer cell lines, of which, 2 and 8 exhibited significant cytotoxic activities toward HL-60 cell and moderate activities against others cell lines.     

3D-pharmacophore study molecular docking and synthesis of pyrido[2,3-d]pyrimidine-4(1H) dione derivatives with in vitro potential anticancer and antioxidant activities

Some poly functionalized heterocyclic-compounds containing pyridine-moieties were readily assembled by combining differently functionalized pyridopyrimidine-6-carbonitrile derivatives 1a,b with different electrophilic and nucleophilic reagents via short synthetic routes. The structures of the prepared derivatives were ascertained from their-spectral-and elemental analyses. Some of the synthesized compounds were tested as plausible antitumor agents. Most of those tested compounds likes 7 , 9 , 10 , 11a showed cytotoxic potencies against different tumor cell lines. In addition, the assessments for their antioxidant activities have also been done and compound 9 exhibited the highest antioxidant activity while compounds 7 and 10 showed moderate activities. Finally, molecular docking studies were carried out which favorably indicated a high support for the experimental-results.     

Synthesis and biological evaluation of new 4beta-5-Fu-substituted 4'-demethylepipodophyllotoxin derivatives

A series of new 4beta-5-Fu-substituted 4'-demethylepipodophyllotoxin derivatives were synthesized and evaluated, together with some previously prepared ones, for their cytotoxic activities against four tumor cell lines (HL60, P388, A549 and BEL7402). Three of these compounds exhibited superior in vitro anticancer activity against P388 and A549 than the reference compound etoposide. In addition, the partition coefficients (P) of all the new and previously synthesized derivatives were determined.     

Synthesis and Characterization of Novel Azo-containing or Azoxy-containing Schiff Bases and Their Antiproliferative and Cytotoxic Activities

A series of novel Schiff base derivatives was designed and synthesized from 3,3'-azobenzaldehyde and 3,3'-azoxybenzaldehyde. The newly synthesized compounds were characterized by FTIR, ¹H NMR, MS and elemental analysis and tested for their in vitro antiproliferative activities against HeLa cell lines. At the same time, the impact on the antitumor activity of the sulfanilamido, benzamido, phenolic hydroxyl or thiourea groups was investigated and discussed. Compounds 4, 6 and 10 were found to exhibit strong cytotoxic activity.